:: Volume 16 - ::
J Babol Univ Med Sci. 2014; Volume 16 Back to browse issues page
Disease Modifying Osteoarthritis Drugs
B. Heidari (MD) * , B. Yousef Ghahari (MD)
Abstract:   (12273 Views)
 

ABSTRACT

 

Osteoarthritis is a common disease and a significant cause of disability in the elderly. Available treatment does not affect the course of osteoarthritis but exerts only a symptomatic effect on pain. Recently many drugs have been introduced with the aim of chondroprotection. Among them glucosamine and chondroitin are the most common drugs which have been used in several studies. Nevertheless, the results vary across various studies. While a chondroprotective effect has been observed in some studies, in a number of studies the effects of glucosamine or chondroitin alone or in combination did not differ with placebo. Different drugs dosages, duration of treatment, and treatment outcomes and study designs have been considered the most important confounders affecting the results of various studies as well as for explanation of the contradictory results. In addition, in a number of studies, drugs such as diacerein, anti-osteoporotic medications, soya bean, and tetracycline have shown chondroprotective potentials in osteoarthritis. This review by comparing the results of available studies provides a rational for prescription of these drugs in osteoarthritis.

 
Keywords: Osteoarthritis, Disease modifying, Glucosamine, Chondroprotection
Full-Text [PDF 419 kb]   (2260 Downloads)    
Type of Study: Research | Subject: Biochemical
Received: 2013/03/9 | Accepted: 2013/07/10 | Published: 2014/08/9



XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16 - Back to browse issues page